|Videos|June 29, 2022
Future Perspectives in Renal Cell Carcinoma (RCC)
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Epkinly Combo in Relapsed/Refractory Follicular Lymphoma
2
Why I’m Excited HRT Is Finally Getting Attention
3
Targeted Therapies Are Transforming Lung Cancer Treatment
4
FDA Fast Tracks ITM-94 For Clear Cell Renal Cell Carcinoma Diagnosis
5
